Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "NITI"

3208 News Found

NITI Aayog releases reports to improve ease of doing R&D in India
Policy | April 10, 2026

NITI Aayog releases reports to improve ease of doing R&D in India

The reports will now be shared with relevant ministries and departments as a guidance framework


Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact
Hospitals | April 09, 2026

Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact

CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change


Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
News | April 09, 2026

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms


Alpha Cognition secures key US patent for traumatic brain injury treatment
Biopharma | April 08, 2026

Alpha Cognition secures key US patent for traumatic brain injury treatment

The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL


Novartis’ Cosentyx gains FDA nod for pediatric hidradenitis suppurativa patients
Drug Approval | March 18, 2026

Novartis’ Cosentyx gains FDA nod for pediatric hidradenitis suppurativa patients

The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options


Alto Neuroscience completes enrollment in Phase 2 trial for first-of-its-kind schizophrenia cognitive treatment
Clinical Trials | February 17, 2026

Alto Neuroscience completes enrollment in Phase 2 trial for first-of-its-kind schizophrenia cognitive treatment

Alto met its enrollment goal with 83 patients across 13 US clinical sites


Merck initiates phase 3 trial of calderasib with Keytruda QLEX for NSCLC
Clinical Trials | January 11, 2026

Merck initiates phase 3 trial of calderasib with Keytruda QLEX for NSCLC

KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer


Indian Vice President calls for global recognition of traditional medicine
News | January 05, 2026

Indian Vice President calls for global recognition of traditional medicine

He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world


Shilpa Medicare receives initial authorization for Rotigotine transdermal patch from Europe
News | December 12, 2025

Shilpa Medicare receives initial authorization for Rotigotine transdermal patch from Europe

This is the first approval of a prescription transdermal dosage Form in the European markets from this facility


Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis
News | December 11, 2025

Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis

Roche says its new assay “resolves this challenge by delivering accurate and specific results